Wednesday, October 04, 2023 12:49:46 AM
A 5 bagger NEXT LEVEL DUMB
Got a story 4 the jury Eddie?
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective March 15th, 2018, a special meeting of the Board of Directors was held to accept the resignation of Kevin Williams as the CEO, President, Secretary, Treasurer, and Director of the Board.
Effective March 15th, 2018, Richard Kilchesky, age 33 was appointed as the new President, CEO, and Chairman of the Board of Directors. Mr. Kilchesky is an expert outdoorsman and fishing guide specializing in remote access resorts and adventures; he has been in this industry for the last 15 Years.
Effective March 15th, 2018 Phillip Kilchesky, age 30 was appointed as the new Treasurer, and will serve on the board of directors at the request of the CEO. Mr. Kilchesky has been employed for six years as a service center supervisor for a leading distributor of electrical, communications, data networking and security products.
Effective March 15th, 2018 Mark Miller, age 40 was appointed Interim Secretary and Advisor. Mr. Miller serves as a consultant to the CEO, but does not serve on the board of directors at this time. Mr. Miller is a Licensed General Contractor in the State of MN with a construction company and a real estate company. Mr. Miller is also the CEO and Board Member of Digitiliti, Inc., a publicly traded company under the ticker symbol DIGI and President, CEO, Secretary and Sole Director of MedX Holdings, Inc., also a publicly traded company under the ticker symbol MEDH.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.
Utilicraft Aerospace Industries, Inc., a Nevada corporation
Date: March 21, 2018
/s/ Richard Kilchesky
Richard Kilchesky, President, CEO, and Chairman of the Board
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM